Pulse Biosciences, Inc. (PLSE) Financials
PLSE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 115.6 million | 16.1 million |
| March 31, 2026 | 81.6 million | 15.3 million |
| Dec. 31, 2025 | 96.1 million | 15.5 million |
| Sept. 30, 2025 | 108.8 million | 16.1 million |
PLSE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -18.8 million | 5.0 million |
| March 31, 2026 | -14.6 million | 1.9 million |
| Dec. 31, 2025 | -14.9 million | 5.0 million |
| Sept. 30, 2025 | -13.1 million | 5.6 million |
PLSE Net Income
No data available :(
PLSE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 101.6 million | - | 6.8 million |
| March 31, 2026 | 68.3 million | - | 7.2 million |
| Dec. 31, 2025 | 80.7 million | - | 6.0 million |
| Sept. 30, 2025 | 95.2 million | - | 7.9 million |
PLSE Shares Outstanding
PLSE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 90000 | 17.0 million | 8.5 million | - |
| March 31, 2026 | 33000 | 12.6 million | 6.6 million | - |
| Dec. 31, 2025 | 105000 | 10.9 million | 7.1 million | - |
| Sept. 30, 2025 | 62000 | 11.4 million | 8.8 million | - |
PLSE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 434000 | 273000 |
| March 31, 2026 | 401000 | 370000 |
| Dec. 31, 2025 | 264000 | 519000 |
| Sept. 30, 2025 | 86000 | 279000 |
PLSE Revenue by Segment
Graph available only for paid members. Upgrade to see it.
PLSE
Price: $45.59
52 week price:
Earnings Per Share: -1.17 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 25600
Ebitda: -14.3 millionMarket Capitalization: 3.3 billion